Concepedia

Publication | Open Access

Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer

DOIFull Paper Access

29

Citations

33

References

2022

Year

Wei Fang Dai, Jaclyn Beca, Chenthila Nagamuthu, Ning Liu, Claire de Oliveira, Craig C. Earle, Maureen Trudeau, Kelvin Chan
JAMA Oncology

Abstract

The findings of this population-based study suggest that pertuzumab may increase survival for patients with metastatic breast cancer but would not be considered cost-effective, even after 100% price reduction, under conventional thresholds.

References

YearCitations

Page 1